161 related articles for article (PubMed ID: 1980152)
1. Pressor responses in rats following intravenous dynorphin A(1-13) administration are blocked by AVP-V1 receptor antagonism.
Thornhill J; Gregor L; Pittman Q
Regul Pept; 1990 Oct; 31(1):1-10. PubMed ID: 1980152
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic responses of conscious rats following intrathecal injections of prodynorphin-derived opioids: independence of action of intrathecal arginine vasopressin.
Thornhill JA; Pittman QJ
Can J Physiol Pharmacol; 1990 Feb; 68(2):174-82. PubMed ID: 1968777
[TBL] [Abstract][Full Text] [Related]
3. Opiate and alpha receptor antagonists block the pressor responses of conscious rats given intravenous dynorphin.
Thornhill JA; Gregor L; Saunders WS
Peptides; 1989; 10(1):171-7. PubMed ID: 2568623
[TBL] [Abstract][Full Text] [Related]
4. Pressor, tachycardic and feeding responses in conscious rats following i.c.v. administration of dynorphin. Central blockade by opiate and alpha 1-receptor antagonists.
Saunders WS; Thornhill JA
Regul Pept; 1987 Nov; 19(3-4):209-20. PubMed ID: 2893437
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin.
Manning M; Stoev S; Bankowski K; Misicka A; Lammek B; Wo NC; Sawyer WH
J Med Chem; 1992 Jan; 35(2):382-8. PubMed ID: 1531076
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment with vasodilator or V1-antagonist abolishes vasopressin withdrawal hypotension in spontaneously hypertensive rats.
Chiu EK; McNeill JR
J Hypertens; 1987 Oct; 5(5):593-8. PubMed ID: 2963065
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular responses to intrathecal vasopressin in conscious and anesthesized rats.
Martinez-Arizala A; Holaday JW; Long JB
Am J Physiol; 1989 Jan; 256(1 Pt 2):R193-200. PubMed ID: 2912212
[TBL] [Abstract][Full Text] [Related]
8. Central effects of somatostatin: pressor response, AVP release, and sympathoinhibition.
Rettig R; Geist R; Sauer U; Rohmeiss P; Unger T
Am J Physiol; 1989 Sep; 257(3 Pt 2):R588-94. PubMed ID: 2571303
[TBL] [Abstract][Full Text] [Related]
9. Contribution of vasopressin in dexamethasone-induced hypertension in rats.
Iijima F; Malik KU
Hypertension; 1988 Feb; 11(2 Pt 2):I42-6. PubMed ID: 3346065
[TBL] [Abstract][Full Text] [Related]
10. Paraventricular nucleus injections of noradrenaline: cardiovascular effects in conscious Long-Evans and Brattleboro rats.
Harland D; Gardiner SM; Bennett T
Brain Res; 1989 Sep; 496(1-2):14-24. PubMed ID: 2553199
[TBL] [Abstract][Full Text] [Related]
11. Increased pressor function of central vasopressinergic system in hypertensive renin transgenic rats.
Szczepańska-Sadowska E; Paczwa P; Loń S; Ganten D
J Hypertens; 1998 Oct; 16(10):1505-14. PubMed ID: 9814623
[TBL] [Abstract][Full Text] [Related]
12. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
Hinojosa C; Haywood JR
J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms underlying the cardiovascular responses to intrathecal vasopressin administration in rats.
Riphagen CL; Pittman QJ
Can J Physiol Pharmacol; 1989 Apr; 67(4):269-75. PubMed ID: 2758369
[TBL] [Abstract][Full Text] [Related]
14. Vascular effects of arginine vasopressin during fluid deprivation in the rat.
Aisenbrey GA; Handelman WA; Arnold P; Manning M; Schrier RW
J Clin Invest; 1981 Apr; 67(4):961-8. PubMed ID: 7204578
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of the depressor action of LY171555, a selective dopamine D2 receptor agonist, in the anesthetized rat.
Nagahama S; Chen YF; Lindheimer MD; Oparil S
J Pharmacol Exp Ther; 1986 Nov; 239(2):426-32. PubMed ID: 3772802
[TBL] [Abstract][Full Text] [Related]
16. Role of AVP in pressor responses during activation of central TxA2/PGH2 receptors.
Wilcox CS; Gao H; Verbalis JG; Welch WJ
Am J Physiol; 1997 Oct; 273(4):H1927-32. PubMed ID: 9362262
[TBL] [Abstract][Full Text] [Related]
17. Central vasopressin raises arterial pressure by sympathetic activation and vasopressin release.
Janiak P; Kasson BG; Brody MJ
Hypertension; 1989 Jun; 13(6 Pt 2):935-40. PubMed ID: 2737730
[TBL] [Abstract][Full Text] [Related]
18. Effects of losartan, prazosin and a vasopressin V1-receptor antagonist on renal and femoral blood flow in conscious sheep.
Ullman J; Eriksson S; Rundgren M
Acta Physiol Scand; 2001 Jan; 171(1):99-104. PubMed ID: 11350268
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a functional relationship between noradrenaline and neurohypophyseal peptides in the brainstem of rats.
Vallejo M; Lightman SL
Brain Res; 1987 Oct; 422(2):295-302. PubMed ID: 3676790
[TBL] [Abstract][Full Text] [Related]
20. Selective cardiovascular and neuroendocrine effects of a kappa-opioid agonist in the nucleus tractus solitarii of rats.
Carter DA; Lightman SL
J Physiol; 1985 Oct; 367():363-75. PubMed ID: 2997441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
